23 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp04476 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Membrane disruption | WST-1 assay | HeLa | Pancreatic cancer | IC50 : > 60 µM |
| dbacp04477 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Membrane perforation | LDH leakage assay | RT4(G1) | Bladder cancer | IC50 : 32.3 µM |
| dbacp04478 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Membrane perforation | LDH leakage assay | 647V(G2) | Bladder cancer | IC50 : 54.1 µM |
| dbacp04479 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Membrane perforation | LDH leakage assay | 486P(G4) | Bladder cancer | IC50 : 28.6 µM |
| dbacp04480 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Membrane perforation | WST-1 assay | RT4(G1) | Bladder cancer | IC50 : 484 µM |
| dbacp04481 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Membrane perforation | WST-1 assay | 647V(G2) | Bladder cancer | IC50 : 52.4 µM |
| dbacp04482 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Membrane perforation | WST-1 assay | 486P(G4) | Bladder cancer | IC50 : 57.8 µM |
| dbacp04483 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Membrane perforation | Cell viability assay | RT4(G1) | Bladder cancer | IC50 : 135.3 µM |
| dbacp04484 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Membrane perforation | Cell viability assay | 647V(G2) | Bladder cancer | IC50 : 31 µM |
| dbacp04485 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Membrane perforation | Cell viability assay | 486P(G4) | Bladder cancer | IC50 : 59.4 µM |
| dbacp04486 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Not specified | MTT/MTS assay | A-549 | Lung cancer | IC50 : 110 µM |
| dbacp04487 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Dissipate ion gradients; Induce osmotic lysis; Membrane damage | Trypan blue assay | U-937 | Lymphoma cancer | IC50 : >150 µg/ml |
| dbacp04488 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Dissipate ion gradients; Induce osmotic lysis; Membrane damage | Trypan blue assay | 8402 | Leukemia cancer | IC50 : >150 µg/ml |
| dbacp04489 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Dissipate ion gradients; Induce osmotic lysis; Membrane damage | Trypan blue assay | SSKT-1 | Hematopoietic cancer | IC50 : >150 µg/ml |
| dbacp04490 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Dissipate ion gradients; Induce osmotic lysis; Membrane damage | Trypan blue assay | Daudi | Colon cancer | IC50 : >150 µg/ml |
| dbacp04491 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Dissipate ion gradients; Induce osmotic lysis; Membrane damage | Trypan blue assay | MLA | Leukemia cancer | IC50 : >150 µg/ml |
| dbacp04492 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Dissipate ion gradients; Induce osmotic lysis; Membrane damage | Trypan blue assay | Raji | Lymphoma cancer | IC50 : >150 µg/ml |
| dbacp04493 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Dissipate ion gradients; Induce osmotic lysis; Membrane damage | Trypan blue assay | K-562 | Leukemia cancer | IC50 : >150 µg/ml |
| dbacp04494 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Dissipate ion gradients; Induce osmotic lysis; Membrane damage | Trypan blue assay | CHP-100 | Ewing sarcoma | IC50 : >200 µg/ml |
| dbacp04495 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Dissipate ion gradients; Induce osmotic lysis; Membrane damage | Trypan blue assay | MCF-7 | Breast cancer | IC50 : >200 µg/ml |
| dbacp04496 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Dissipate ion gradients; Induce osmotic lysis; Membrane damage | Trypan blue assay | PC-3 | Prostate cancer | IC50 : >200 µg/ml |
| dbacp04497 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | Yunnan firebelly toad | Membrane perforation | Cell viability assay | 486P(G4) | Bladder cancer | IC50 : 59.4 µM |
| dbacp04498 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | Skin; Stomach, African clawed frog, Africa | Membrane disruption | Not specified | Not found | Not found | Not found |